Experienced Chief Commercial Officer with a proven track record in the cell and gene therapy industry. Dedicated to addressing challenges in developing and manufacturing cell-based therapeutics, particularly focusing on cGMP materials. Committed to advancing these therapies as a priority, both in my professional role and through my involvement with The Emily Whitehead Foundation.